Louisiana Health Service & Indemnity Company et al v. Celgene Corporation et al
| Louisiana Health Service & Indemnity Company individually and on behalf of all others similarly situated doing business as Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc. |
| Celgene Corporation, Bristol Myers Squibb Company, Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Eugia Pharma Specialties Limited, Breckenridge Pharmaceutical, Inc., Natco Pharma Limited, Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Limited |
| 1:2023cv07871 |
| September 5, 2023 |
| US District Court for the Southern District of New York |
| Edgardo Ramos |
| Anti-Trust |
| 15 U.S.C. § 1 Antitrust Litigation (Monopolizing Trade) |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 19, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 58 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Other Affiliate TOWA Pharmaceutical, Co., Ltd. for Breckenridge Pharmaceutical, Inc.. Document filed by Breckenridge Pharmaceutical, Inc...(Zappia, Andrew) |
Filing 57
STIPULATION TO EXTEND CELGENE CORPORATION'S AND BRISTOL MYERS SQUIBB COMPANY'S DEADLINES TO RESPOND TO PLAINTIFFS' CLASS ACTION COMPLAINT: IT IS HEREBY STIPULATED and AGREED, by and between the Parties by their undersigned counsel, and SO ORDERED by the Court that Celgene's and BMS's deadlines to answer, move, or otherwise respond to the Complaint are the earlier of ( a) December 19, 2023, or (b) the date on which Celgene and BMS are required to answer, move, or otherwise respond to another complaint alleging the same or a similar set of facts as the Complaint in this action. The request to extend the time to respond to the complaint, until December 19, 2023, is granted. SO ORDERED. Bristol Myers Squibb Company answer due 12/19/2023; Celgene Corporation answer due 12/19/2023., Motions terminated: #53 CONSENT MOTION for Extension of Time to File Answer re: #6 Complaint, filed by Celgene Corporation, Bristol Myers Squibb Company. (Signed by Judge Edgardo Ramos on 10/10/2023) (ama)
|
|
Filing 56
ORDER: granting #50 Letter Motion for Extension of Time to Answer re #50 LETTER MOTION for Extension of Time to File Answer re: #1 Complaint. addressed to Judge Edgardo Ramos from Andrew P. Zappia dated October 6, 2023. The request to extend the time to respond to the complaint, until December 19, 2023, is granted. SO ORDERED. Breckenridge Pharmaceutical, Inc. answer due 12/19/2023. (Signed by Judge Edgardo Ramos on 10/10/2023) (ama)
|
| Filing 55 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Eugia Pharma Specialties Limited. Document filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Eugia Pharma Specialties Limited..(Scaccia, Giancarlo) |
| Filing 54 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Bristol Myers Squibb Company, Celgene Corporation..(Kurtzer-Ellenbogen, David) |
| Filing 53 CONSENT MOTION for Extension of Time to File Answer re: #6 Complaint, . Document filed by Bristol Myers Squibb Company, Celgene Corporation..(Kurtzer-Ellenbogen, David) |
| Filing 52 NOTICE OF APPEARANCE by Benjamin M. Greenblum on behalf of Bristol Myers Squibb Company, Celgene Corporation..(Greenblum, Benjamin) |
| Filing 51 NOTICE OF APPEARANCE by David Simon Kurtzer-Ellenbogen on behalf of Bristol Myers Squibb Company, Celgene Corporation..(Kurtzer-Ellenbogen, David) |
| Filing 50 LETTER MOTION for Extension of Time to File Answer re: #1 Complaint,, addressed to Judge Edgardo Ramos from Andrew P. Zappia dated October 6, 2023. Document filed by Breckenridge Pharmaceutical, Inc...(Zappia, Andrew) |
| Filing 49 NOTICE OF APPEARANCE by Andrew Peter Zappia on behalf of Breckenridge Pharmaceutical, Inc...(Zappia, Andrew) |
| Filing 48 SUMMONS RETURNED EXECUTED. Aurobindo Pharma USA, Inc. served on 9/13/2023, answer due 10/4/2023. Service was accepted by Richard Kelly, Paralegal. Document filed by HMO Louisiana, Inc.; Louisiana Health Service & Indemnity Company..(Street, Whitney) |
|
Filing 47
ORDER granting #40 Motion for Kristen A. Johnson to Appear Pro Hac Vice. (HEREBY ORDERED by Judge Edgardo Ramos)(Text Only Order) (jar)
|
|
Filing 46
ORDER granting #31 Motion for Thomas M. Sobol to Appear Pro Hac Vice. (HEREBY ORDERED by Judge Edgardo Ramos)(Text Only Order) (jar)
|
|
Filing 45
ORDER granting #30 Motion for Claudia Morera to Appear Pro Hac Vice. (HEREBY ORDERED by Judge Edgardo Ramos)(Text Only Order) (jar)
|
|
Filing 44
PLAINTIFFS' NOTICE OF VOLUNTARY DISMISSAL OF DEFENDANTS TEVA PHARMACEUTICALS USA AND TEVA PHARMACEUTICAL INDUSTRIES LIMITED: Pursuant to Fed. R. Civ. P. 41(a)(1)(A)(i), the plaintiffs, Louisiana Health Service & Indemnity Company d/b/a Blue Cross and Blue Shield and HMO Louisiana, Inc., voluntarily dismiss the above-caption matter, without prejudice, against defendants Teva Pharmaceuticals USA and Teva Pharmaceutical Industries Limited (collectively, Teva). Rule 41(a)(1)(A) provides for voluntary dismissal of an action by a plaintiff. Should the plaintiff file a notice of dismissal before the service of an answer or motion for summary judgment by the opposing party, Fed. R. Civ. P. 41(a)(1)(A)(i) applies and allows dismissal without a court order. Teva has neither answered the complaint nor filed a motion for summary judgment. The plaintiffs voluntarily dismiss all claims in the above-caption matter, without prejudice, against Teva. This notice applies only to the claims against Teva. All of plaintiffs claims against the other named defendants remain pending and unaffected. SO ORDERED.., Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals USA, Inc. terminated. (Signed by Judge Edgardo Ramos on 10/02/2023) (ama)
|
|
Filing 43
STIPULATION TO EXTEND AUROBINDO PHARMA USA, INC.'S AND AUROLIFE PHARMA LLC'S DEADLINES TO RESPOND TO PLAINTIFFS' CLASS ACTION COMPLAINT: IT IS HEREBY STIPULATED and AGREED, by and between the Parties by their undersigned counsel, and SO ORDERED by the Court that: Aurobindo Pharma's and Aurolife's deadlines to answer, move, or otherwise respond to the Complaint are the earlier of (a) December 19, 2023, or (b) the date on which Aurobindo Pharma and Aurolife are required to answer, move or otherwise respond to another complaint alleging the same or a similar set of facts as the Complaint filed in this action. SO ORDERED., Aurobindo Pharma USA, Inc. answer due 12/19/2023; Aurolife Pharma LLC answer due 12/19/2023., Motions terminated: #39 CONSENT MOTION for Extension of Time to File Answer re: #6 Complaint, filed by Aurobindo Pharma USA, Inc., Eugia Pharma Specialties Limited, Aurobindo Pharma Limited, Aurolife Pharma LLC. (Signed by Judge Edgardo Ramos on 10/02/2023) (ama)
|
| ***NOTICE TO COURT REGARDING NOTICE OF VOLUNTARY DISMISSAL Document No. #42 Notice of Voluntary Dismissal, was reviewed and referred to Judge Edgardo Ramos for approval for the following reason(s): the plaintiff(s) filed their voluntary dismissal and it did not dismiss all of the parties or the action in its entirety. (tp) |
| Filing 42 NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, without prejudice and without costs against the defendant(s) Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc.. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Street, Whitney) |
| Filing 41 NOTICE OF APPEARANCE by Brian Harry Rubenstein on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Eugia Pharma Specialties Limited..(Rubenstein, Brian) |
| Filing 40 MOTION for Kristen A. Johnson to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-28338307. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company. (Attachments: #1 Exhibit Affidavit of Kristen A. Johnson, #2 Exhibit Certificate of Good Standing, #3 Exhibit Proposed Order).(Street, Whitney) |
| >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #40 MOTION for Kristen A. Johnson to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-28338307. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (dsh) |
| Filing 39 CONSENT MOTION for Extension of Time to File Answer re: #6 Complaint, . Document filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Eugia Pharma Specialties Limited..(Wise, Jonathan) |
| Filing 38 WAIVER OF SERVICE RETURNED EXECUTED. Eugia Pharma Specialties Limited waiver sent on 9/22/2023, answer due 11/21/2023. Document filed by Eugia Pharma Specialties Limited..(Wise, Jonathan) |
| Filing 37 WAIVER OF SERVICE RETURNED EXECUTED. Aurobindo Pharma Limited waiver sent on 9/22/2023, answer due 11/21/2023. Document filed by Aurobindo Pharma Limited..(Wise, Jonathan) |
| Filing 36 NOTICE OF APPEARANCE by Jonathan Richard Wise on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Eugia Pharma Specialties Limited..(Wise, Jonathan) |
| Filing 35 NOTICE OF APPEARANCE by Giancarlo Scaccia on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Eugia Pharma Specialties Limited..(Scaccia, Giancarlo) |
| Filing 34 NOTICE OF APPEARANCE by Sarah Atlas on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Eugia Pharma Specialties Limited..(Atlas, Sarah) |
| Filing 33 WAIVER OF SERVICE RETURNED EXECUTED. Eugia Pharma Specialties Limited waiver sent on 9/22/2023, answer due 11/21/2023. Document filed by HMO Louisiana, Inc.; Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 32 WAIVER OF SERVICE RETURNED EXECUTED. Aurobindo Pharma Limited waiver sent on 9/22/2023, answer due 11/21/2023. Document filed by HMO Louisiana, Inc.; Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 31 MOTION for Thomas M. Sobol to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-28310126. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company. (Attachments: #1 Exhibit Affidavit of Thomas M. Sobol, #2 Exhibit Certificate of Good Standing, #3 Exhibit Proposed Order).(Street, Whitney) |
| >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #31 MOTION for Thomas M. Sobol to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-28310126. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (vba) |
| Filing 30 MOTION for Claudia Morera to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company. (Attachments: #1 Exhibit Affidavit of Claudia Morera, #2 Exhibit Certificate of Good Standing, #3 Exhibit Proposed Order).(Street, Whitney) |
| >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #30 MOTION for Claudia Morera to Appear Pro Hac Vice. Motion and supporting papers to be reviewed by Clerk's Office staff. The document has been reviewed and there are no deficiencies. (va) |
| Filing 29 WAIVER OF SERVICE RETURNED EXECUTED. Bristol Myers Squibb Company waiver sent on 9/11/2023, answer due 11/13/2023; Celgene Corporation waiver sent on 9/11/2023, answer due 11/13/2023. Document filed by HMO Louisiana, Inc.; Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 28 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Claudia Morera to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number ANYSDC-28289671. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company. (Attachments: #1 Affidavit Affidavit of Claudia Morera, #2 Exhibit Certificate of Good Standing, #3 Proposed Order Proposed Order).(Street, Whitney) Modified on 9/14/2023 (va). |
| >>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. #28 MOTION for Claudia Morera to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number ANYSDC-28289671. Motion and supporting papers to be reviewed by Clerk's Office staff. The filing is deficient for the following reason(s): missing Certificate of Good Standing from Supreme Court of Massachusetts. Re-file the motion as a Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order. (va) |
| Filing 27 ELECTRONIC SUMMONS ISSUED as to Teva Pharmaceutical Industries Limited. (vf) |
| Filing 26 ELECTRONIC SUMMONS ISSUED as to Teva Pharmaceuticals USA, Inc.. (vf) |
| Filing 25 ELECTRONIC SUMMONS ISSUED as to Natco Pharma Limited. (vf) |
| Filing 24 ELECTRONIC SUMMONS ISSUED as to Celgene Corporation. (vf) |
| Filing 23 ELECTRONIC SUMMONS ISSUED as to Bristol Myers Squibb Company. (vf) |
| Filing 22 ELECTRONIC SUMMONS ISSUED as to Breckenridge Pharmaceutical, Inc.. (vf) |
| Filing 21 ELECTRONIC SUMMONS ISSUED as to Eugia Pharma Specialties Limited. (vf) |
| Filing 20 ELECTRONIC SUMMONS ISSUED as to Aurolife Pharma LLC. (vf) |
| Filing 19 ELECTRONIC SUMMONS ISSUED as to Aurobindo Pharma USA, Inc.. (vf) |
| Filing 18 ELECTRONIC SUMMONS ISSUED as to Aurobindo Pharma Limited. (vf) |
| Filing 17 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 16 REQUEST FOR ISSUANCE OF SUMMONS as to Teva Pharmaceuticals USA, Inc., re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 15 REQUEST FOR ISSUANCE OF SUMMONS as to Teva Pharmaceutical Industries Limited, re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 14 REQUEST FOR ISSUANCE OF SUMMONS as to Natco Pharma Limited, re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 13 REQUEST FOR ISSUANCE OF SUMMONS as to Celgene Corporation, re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 12 REQUEST FOR ISSUANCE OF SUMMONS as to Bristol Myers Squibb Company, re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 11 REQUEST FOR ISSUANCE OF SUMMONS as to Breckenridge Pharmaceutical, Inc., re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 10 REQUEST FOR ISSUANCE OF SUMMONS as to Eugia Pharma Specialties Limited, re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 9 REQUEST FOR ISSUANCE OF SUMMONS as to Aurolife Pharma LLC, re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 8 REQUEST FOR ISSUANCE OF SUMMONS as to Aurobindo Pharma USA, Inc., re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 7 REQUEST FOR ISSUANCE OF SUMMONS as to Aurobindo Pharma Limited, re: #6 Complaint,. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 6 COMPLAINT against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Breckenridge Pharmaceutical, Inc., Bristol Myers Squibb Company, Celgene Corporation, Eugia Pharma Specialties Limited, Natco Pharma Limited, Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc.. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
|
Filing 5
ORDER granting #4 Letter Motion for Leave to File Document. The application to file a corrected complaint to include the full signature block is GRANTED. (HEREBY ORDERED by Judge Edgardo Ramos)(Text Only Order) (jar)
|
| Filing 4 LETTER MOTION for Leave to File Corrected Complaint addressed to Judge Edgardo Ramos from Whitney E. Street dated September 6, 2023. Document filed by HMO Louisiana, Inc., Louisiana Health Service & Indemnity Company..(Street, Whitney) |
| Filing 3 CIVIL COVER SHEET filed..(Street, Whitney) |
| ***NOTICE TO ATTORNEY REGARDING DEFICIENT CIVIL COVER SHEET. Notice to attorney Whitney Erin Street to RE-FILE Document No. #2 Civil Cover Sheet. The filing is deficient for the following reason(s): the PDF attached to the docket entry for the civil cover sheet is not correct; invalid Nature of Suit and Basis of Jurisdiction code selection; the PDF was not properly signed by the attorney. Re-file the document using the event type Civil Cover Sheet found under the event list Other Documents and attach the correct PDF. Use civil cover sheet issued by S.D.N.Y. dated October 1, 2020. The S.D.N.Y. Civil Cover Sheet dated October 1, 2020 is located at#http://nysd.uscourts.gov/file/forms/civil-cover-sheet.. (jgo) |
| ***NOTICE TO ATTORNEY REGARDING CIVIL CASE OPENING STATISTICAL ERROR CORRECTION: Notice to attorney Whitney Erin Street. The following case opening statistical information was erroneously selected/entered: County code New York; Fee Status code due (due);. The following correction(s) have been made to your case entry: the County code has been modified to XX Out of State; the Fee Status code has been modified to pd (paid);. (jgo) |
| Magistrate Judge Valerie Figueredo is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (jgo) |
| Case Designated ECF. (jgo) |
| CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Edgardo Ramos. Please download and review the Individual Practices of the assigned District Judge, located at #https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #https://nysd.uscourts.gov/rules/ecf-related-instructions..(jgo) |
| Filing 2 FILING ERROR - PDF ERROR - CIVIL COVER SHEET filed..(Street, Whitney) Modified on 9/6/2023 (jgo). |
| Filing 1 COMPLAINT against AUROLIFE PHARMA LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Breckenridge Pharmaceutical, Inc., Bristol Myers Squibb Company, Celgene Corporation, EUGIA PHARMA SPECIALTIES LIMITED, Natco Pharma Limited, Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc.. (Filing Fee $ 402.00, Receipt Number ANYSDC-28240831)Document filed by HMO LOUISIANA, INC., Louisiana Health Service & Indemnity Company d/b/a Blue Cross and Blue Shield of Louisiana..(Street, Whitney) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
